Trial intelligence / Profile preview

Hypertonic Lactate Solution in CABG Patients

NCT00529711Phase 3Completed

Sponsor
Innogene Kalbiotech
Start
Jul 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of hypertonic sodium lactate in low cardiac output syndrome (LCOS), sponsored by Innogene Kalbiotech. Started Jul 2005; status: completed.

02

Drugs

hypertonic sodium lactate
03

Conditions

low cardiac output syndrome (LCOS)

Beyond the preview

Go deeper on NCT00529711.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00529711.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call